| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.12 | 7e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.17 | 7e-05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-05 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |